Eprosartan Mesylate | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Eprosartan Mesylate
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Eprosartan Mesylate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 10 USDMF, 4 EU WC, 1 KDMF, 5 NDC API, 5 Listed Suppliers, $ API Reference Price

11 API Suppliers
10 USDMF
4 EU WC
1 KDMF
5 NDC API
5 Listed Suppliers
$ API Reference Price

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

11 FDF Dossiers, 7 FDA Orange Book, 4 Europe

11 FDF Dossiers
7 FDA Orange Book
4 Europe

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 11 DKSH, 4 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 25 BASF, 10 Corel Pharma Chem, 4 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 32 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 14 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 30 Controlled & Modified Release, 26 Solubilizers, 26 Direct Compression, 22 Thickeners and Stabilizers, 21 Disintegrants & Superdisintegrants, 21 Granulation, 15 Topical, 13 Film Formers & Plasticizers, 13 Parenteral, 13 Lubricants & Glidants, 11 Co-Processed Excipients, 9 Chewable & Orodispersible Aids, 8 Emulsifying Agents, 7 Taste Masking, 6 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents

65 Fillers, Diluents & Binders
51 Coating Systems & Additives
30 Controlled & Modified Release
26 Solubilizers
26 Direct Compression
22 Thickeners and Stabilizers
21 Disintegrants & Superdisintegrants
21 Granulation
15 Topical
13 Film Formers & Plasticizers
13 Parenteral
13 Lubricants & Glidants
11 Co-Processed Excipients
9 Chewable & Orodispersible Aids
8 Emulsifying Agents
7 Taste Masking
6 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
3 Rheology Modifiers
2 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

2 Finished Drug Prices

2 Finished Drug Prices

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 Health Canada Patents

4 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 222 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 2BGP Pharma ULC

02 2Solvay Pharma Inc.

filter Patent Reset all filters

4 All

01 22115170

02 22250395

filter Product Reset all filters

4 All

01 2Eprosartan Mesylate

02 2Eprosartan mesylate

filter Dosage Reset all filters

4 All

01 4Tablet

filter Exp Date Reset all filters

4 All

01 22012-08-12

02 22017-03-26

Product Main Page

01

BGP Pharma ULC

Eprosartan Mesylate

The Generic Rx Session

Not Confirmed

BGP Pharma ULC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-03-26

Date Granted : 2005-09-06

Eprosartan Mesylate

Brand Name : TEVETEN

Patent Number : 2250395

Filing Date : 1997-03-26

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-03-26

Date Granted : 2005-09-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

BGP Pharma ULC

Eprosartan Mesylate

The Generic Rx Session

Not Confirmed

BGP Pharma ULC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2017-03-26

Date Granted : 2005-09-06

Eprosartan Mesylate

Brand Name : TEVETEN

Patent Number : 2250395

Filing Date : 1997-03-26

Strength per Unit : 600 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2017-03-26

Date Granted : 2005-09-06

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Solvay Pharma Inc.

Eprosartan Mesylate

The Generic Rx Session

Not Confirmed

Solvay Pharma Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-08-12

Date Granted : 2004-05-25

Eprosartan Mesylate

Brand Name : TEVETEN

Patent Number : 2115170

Filing Date : 1992-08-12

Strength per Unit : 400 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-08-12

Date Granted : 2004-05-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Solvay Pharma Inc.

Eprosartan Mesylate

The Generic Rx Session

Not Confirmed

Solvay Pharma Inc.

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-08-12

Date Granted : 2004-05-25

Eprosartan Mesylate

Brand Name : TEVETEN

Patent Number : 2115170

Filing Date : 1992-08-12

Strength per Unit : 600 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-08-12

Date Granted : 2004-05-25

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!